Nitric oxide — soluble guanylate cyclase — cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targets

Nitric oxide — soluble guanylate cyclase — cyclic guanosine monophosphate signaling pathway in the pathogenesis of heart failure and search for novel therapeutic targets

Heart failure is a severe disease with an unfavorable prognosis, which requires intensification of therapy and the search for novel approaches to treatment. In this review, the physiological significance of soluble guanylate cyclase-related signaling pathway, reasons for decrease in its activity in...

Full description

Bibliographic Details
Main Authors:	Zh. D. Kobalava, P. V. Lazarev
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2021-10-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	сердечная недостаточность гуанилатциклаза сигнальный путь
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/3035

Similar Items

Tumor stem cells from glioblastoma multiforme
by: Z. N. Nikiforova, et al.
Published: (2016-06-01)

Wnt-signaling pathway in pathogenesis of glioblastoma multiforme
by: Yu. D. Vasilets, et al.
Published: (2019-01-01)

Влияние воспаления на течение асептического некроза головки бедренной кости в эксперименте.
by: Nikita Andreevich Shabaldin, et al.
Published: (2019-08-01)

Use of the Hedgehog signaling pathway inhibitor in the treatment of recurrent locally advanced and metastatic basal cell skin cancer
by: Z. A.-G. Radzhabova, et al.
Published: (2020-02-01)

Pathogenesis of Cardiac Depression in Acute Destructive Pancreatitis
by: A. V. Ershov, et al.
Published: (2016-02-01)

Pathogenesis of chronic heart failure: change of dominating paradigm
by: V. V. Kalyuzhin, et al.
Published: (2007-12-01)

Cellular and molecular mechanisms of osteoporosis: current concepts and future direction treatment
by: A. T. Dolzhenko, et al.
Published: (2016-06-01)

The nitric oxide–soluble guanylate cyclase–cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase
by: Raymond L. Benza, et al.
Published: (2024-03-01)

KEY PATHOGENETIC ASPECTS AND CLINICAL RELEVANCE OF MECHANICAL DYSSYNCHRONY
by: Yu. V. Stavtseva, et al.
Published: (2015-09-01)

THE ROLE OF CARBON MONOXIDE IN THE REGULATION OF ELECTRICAL AND CONTRACTILE PROPERTIES OF SMOOTH MUSCLE CELLS OF THE GUINEA PIG URETER
by: I. V. Kovalyov, et al.
Published: (2014-02-01)

ОСТРАЯ СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ. ЕВРОПЕЙСКИЙ КОНСЕНСУС: ПЕРЕВОД РЕКОМЕНДАЦИЙ
by: Н. Т. Ватутин, et al.
Published: (2015-08-01)

Modern concept of diastolic heart failure
by: F. T. Ageev
Published: (1970-01-01)

NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS
by: O. M. Drapkina, et al.
Published: (2015-09-01)

PREDICTIVE VALUE OF CARDIAC CACHEXIA IN CHRONIC HEART FAILURE
by: E. S. Drobysheva, et al.
Published: (2016-08-01)

Inhibition of growth of colorectal cancer patient-derived subcutaneous xenografts using combined Wnt signaling pathway inhibitor and 5‑fluorouracil
by: A. S. Goncharova, et al.
Published: (2022-03-01)

Systolic longitudinal strain and congestive heart failure in patients with moderate ischemic mitral insufficiency before and after surgical revascularization and mitral annuloplasty
by: С. Г. Суханов, et al.
Published: (2015-10-01)

Prognostic value of short-term trajectories of left ventricular ejection fraction in patients with first myocardial infarction and percutaneous coronary intervention
by: T. M. Timofeeva, et al.
Published: (2023-01-01)

Anti-cancer activity of сuraxin CBL0137 on the models of acute leukemia in vitro
by: T. I. Fetisov, et al.
Published: (2019-12-01)

Genetic polymorphism of immunogenic signaling system
by: V. N. Tzygan, et al.
Published: (2014-09-01)

Effect of therapy on the dynamics of collagen metabolism markers in older patients with heart failure with mid-range ejection fraction and coronary artery disease
by: O. A. Osipova, et al.
Published: (2020-11-01)

Фармакоэкономический анализ применения левосимендана у больных с тяжёлой декомпенсированной хронической сердечной недостаточностью
Published: (2018-06-01)

Ингибитор фосфодиэстеразы-5 в лечении легочной артериальной гипертензии
Published: (2019-09-01)

Cardiac contractility modulation in treatment of patients with chronic heart failure
by: Ю. В. Мареев
Published: (2015-10-01)

CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA
by: M. V. Melnik, et al.
Published: (2015-12-01)

Первый опыт расширенной миоэктомии при хирургическом лечении обструктивной гипертрофической кардиомиопатии: непосредственные и промежуточные результаты
by: А. В. Богачев-Прокофьев, et al.
Published: (2015-10-01)

EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION
by: K. G. Adamyan, et al.
Published: (2016-01-01)

EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE
by: V. N. Larina, et al.
Published: (2016-01-01)

NEW OPPORTUNITIES FOR PREVENTIVE THERAPY WITH STATINS DURING CHD PATIENTS’ REHABILITATION, WITH CLINICAL SIGNS OF MODERATE CHF: EFFECTIVENESS OF ROSUVASTATIN AND EZETIMIBE
by: N. I. Tarasov, et al.
Published: (2016-06-01)

CLINICAL ASPECTS OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE IN ELDERLY PATIENTS WITH CARDIOVASCULAR PATHOLOGY
by: E. G. Martemianova
Published: (2018-04-01)

Melatonin and cardiovascular disease: from mechanisms of action to potential clinical use (literature review)
by: O. M. Drapkina, et al.
Published: (2022-01-01)

Physical training – modulator of peripheral factors for chronic heart failure development
by: A. S. Noskova, et al.
Published: (2007-02-01)

Heart failure as a risk factor of adverse drug reactions. Part 1: potential changes in pharmacokinetics
by: A. P. Pereverzev, et al.
Published: (2022-02-01)

Echocardiographic characteristics of patients with ischemic and non-ischemic chronic heart failure with reduced ejection fraction
by: N. N. Ilov, et al.
Published: (2022-10-01)

Mutation profile of diffuse large B-cell lymphoma with relapses in the central nervous system
by: E. N. Voropaeva, et al.
Published: (2022-10-01)

Anaemia and chronic heart failure
by: T. A. Kazantseva, et al.
Published: (2010-08-01)

Allosteric activation of the nitric oxide receptor soluble guanylate cyclase mapped by cryo-electron microscopy
by: Benjamin G Horst, et al.
Published: (2019-09-01)

Surgical treatment of secondary mitral regurgitation in heart failure: a present-day view
by: E. G. Agafonov, et al.
Published: (2021-03-01)

Spirapril – a modern ACE inhibitor
by: V. M. Gorbunov
Published: (2005-06-01)

Structural Perspectives on the Mechanism of Soluble Guanylate Cyclase Activation
by: Elizabeth C. Wittenborn, et al.
Published: (2021-05-01)

TRANSCRIPTION FACTOR BRN-3α AND PROSTATE CANCER, RELATION WITH HORMONE RECEPTORS AND AKT/M-TOR SIGNALING PATHWAY ACTIVATION
by: L. V. Spirina, et al.
Published: (2018-03-01)